Press Releases

Showing 1-35 of 181


2014

April

April 16

Abbott Reports First-Quarter 2014 Results

April 14

Abbott Announces FDA Clearance for a New Test to Help Physicians Quickly and Accurately Diagnose Diabetes

April 10

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

April 1

Abbott Hosts Conference Call for First-Quarter Earnings
 

March

March 28

Abbott Announces FDA Approval of Its Supera® Stent to Treat People with Peripheral Artery Disease
 

February

February 25

Abbott Recognizes Recipients of Supplier Excellence Award

February 21

Abbott Declares 361st Consecutive Quarterly Dividend
 

January

January 22

Abbott Reports Fourth-Quarter and Full-Year 2013 Results

January 6

Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2013 Earnings

2013

December

December 19

Abbott to Present at J.P. Morgan Healthcare Conference

December 17

A Space Age View into Human Vision: Abbott's iDesign Dx System Now Available for U.S. Ophthalmologists and Patients
 

November

November 27

Abbott Issues Voluntary Recall of Certain FreeStyle® and FreeStyle Lite® Blood Glucose Test Strips in the United States

November 18

Abbott Named Top Dealmaker for Sixth Consecutive Year by The Deal

November 13

Statement | Abbott Supports Relief Efforts in the Philippines

November 12

Tiësto Teams Up with Music Saves Lives® and Abbott to Encourage Young People to Donate Blood

November 7

Similac® Partners with National Association of Hispanic Nurses® to Launch StrongMoms® Español

November 6

Partners In Health, Abbott and the Abbott Fund Open Nutrition Facility in Haiti
 

October

October 30

Abbott's MitraClip® Treatment Demonstrates Positive Results for Patients with Degenerative Mitral Regurgitation at Prohibitive Risk for Surgery

October 25

Abbott's First-In-Class MitraClip® Device Now Available for U.S. Patients

October 24

Abbott Again Recognized by Science Magazine as One of the Top Employers in the Healthcare Industry

October 18

New Study Demonstrates Importance of Oral Nutritional Supplements in Helping Hospitals Achieve Medicare Readmission Reduction Requirements

October 16

Abbott Reports Third-Quarter 2013 Results

October 11

New Study Shows Oral Nutritional Supplement Use in Pediatric Inpatients Is Associated with Decreases in Length of Hospital Stay, Costs
 

September

September 25

Abbott Hosts Conference Call for Third-Quarter Earnings

September 17

Abbott Ranked Among Top 10 Best Companies by Working Mother Magazine

September 17

Abbott Receives CE Mark for FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System™

September 12

Abbott Named the Leading Healthcare Company on the Dow Jones Sustainability Index (DJSI)

September 12

Abbott Declares 359th Consecutive Quarterly Dividend

September 4

New Data Suggests Abbott's High Sensitive Troponin Test May Help Doctors More Accurately Diagnose Heart Attacks in Women
 

August

August 30

Oral Nutritional Supplements in the Hospital Demonstrate Significant Health and Cost Benefits in New Research

August 21

Abbott Completes Acquisition of IDEV Technologies

August 19

Abbott Completes Acquisition of OptiMedica

August 15

Abbott Partners with Music Saves Lives® to Encourage Young Donors to Give the Gift of Blood
 

July

July 30

New Data for Abbott’s Investigational High Sensitive Troponin Test Shows It May Help Doctors Predict Heart Attack Risk

July 29

Abbott Features Solutions to Help Labs Prepare for the Evolving Healthcare Landscape at the American Association for Clinical Chemistry Lab Expo